Big pharma "needs to play ball" after Washington backs AIDS patent pool
This article was originally published in Scrip
Executive Summary
The US government has come out with its strongest support yet for the AIDS medicines patent pool, piling pressure on pharmaceutical companies to license their patent rights to the pool so that generic firms can make affordable fixed-dose combination antiretrovirals for developing countries.